文献速递中毒与环境急症消化、代谢与肾脏急症

州法律允许药房直接发放纳洛酮与致命过量风险之间的关联

Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose.
PubMed 文献 · JAMA Intern Med · 2019-01-01
一句话结论授权药师直接发放纳洛酮的州法律与阿片类致命过量减少相关,但非致命过量急诊就诊可能增加。

该研究采用双重差分法分析2005至2016年美国50州及哥伦比亚特区通过纳洛酮获取法律(NALs)后致命与非致命过量的变化。授权药师直接发放纳洛酮的法律在通过3年及以上时,每10万人阿片类致命过量估计减少0.387(95%CI 0.119-0.656;P=.007),效应随时间增大;间接授权法律(增加0.121;95%CI -0.014至0.257;P=.09)和其他NALs(增加0.094;95%CI -0.040至0.227;P=.17)关联证据很少。作者认为仅直接发放法律似乎有用,纳洛酮可及性改善的社区应准备非致命过量增加并将个体链接至有效治疗。

要点

  • 授权药师直接发放纳洛酮的州法律在通过3年及以上时,每10万人阿片类致命过量估计减少0.387(95%CI 0.119-0.656;P=.007)。
  • 间接授权药师发放的法律与致命过量关联证据很少(增加0.121;95%CI -0.014至0.257;P=.09)。
  • 其他类型纳洛酮获取法律与致命过量关联证据很少(增加0.094;95%CI -0.040至0.227;P=.17)。
  • 直接授权法律与致命过量减少的效应量随时间相对法律通过时间增大。
  • 直接授权法律可能增加急诊就诊的非致命过量;作者建议改善纳洛酮可及的社区准备非致命过量增加并链接至有效治疗。

适用人群与场景

  • 美国50个州及哥伦比亚特区的全州人群,评估2005至2016年通过纳洛酮获取法律(NALs)后的致命与非致命过量变化。
  • 比较通过NALs的州与未通过NALs的州。

研究设计与关键结果

  • 研究设计:州级双重差分分析,评估2005至2016年50个州及哥伦比亚特区通过NALs后致命与非致命过量的变化,研究于2017年1月至2019年1月进行。
  • 主要结局:阿片类致命过量;次要结局:导致急诊就诊的非致命过量和医疗补助纳洛酮处方。
  • 直接授权药师发放纳洛酮的法律在通过3年及以上时,每10万人阿片类致命过量估计减少0.387(95%CI 0.119-0.656;P=.007),效应量随时间相对法律通过时间增大。
  • 间接授权药师发放的法律与致命过量关联证据很少(增加0.121;95%CI -0.014至0.257;P=.09)。
  • 其他NALs与致命过量关联证据很少(增加0.094;95%CI -0.040至0.227;P=.17)。
  • 直接授权法律可能增加急诊就诊的非致命过量。

证据类型、等级与局限

  • 证据类型:州级双重差分分析(观察性研究)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,仅允许药师直接发放纳洛酮的法律似乎有用;纳洛酮可及性改善的社区应准备非致命过量增加,并将这些个体链接至有效治疗。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Given high rates of opioid-related fatal overdoses, improving naloxone access has become a priority. States have implemented different types of naloxone access laws (NALs) and there is controversy over which of these policies, if any, can curb overdose deaths. We hypothesize that NALs granting direct authority to pharmacists to provide naloxone will have the greatest potential for reducing fatal overdoses.

OBJECTIVES: To identify which types of NALs, if any, are associated with reductions in fatal overdoses involving opioids and examine possible implications for nonfatal overdoses.

DESIGN, SETTING, AND PARTICIPANTS: State-level changes in both fatal and nonfatal overdoses from 2005 to 2016 were examined across the 50 states and the District of Columbia after adoption of NALs using a difference-in-differences approach while estimating the magnitude of the association for each year relative to time of adoption. Policy environments across full state populations were represented in the primary data set. The association for 3 types of NALs was associated: NALs providing direct authority to pharmacists to prescribe, NALs providing indirect authority to prescribe, and other NALs. The study was conducted from January 2017 to January 2019.

EXPOSURES: Fatal and nonfatal overdoses in states that adopted NAL laws were compared with those in states that did not adopt NAL laws. Further consideration was given to the type of NAL passed in terms of its association with these outcomes. We hypothesize that NALs granting direct authority to pharmacists to provide naloxone will have the greatest potential for reducing fatal overdoses.

MAIN OUTCOMES AND MEASURES: Fatal overdoses involving opioids were the primary outcome. Secondary outcomes were nonfatal overdoses resulting in emergency department visits and Medicaid naloxone prescriptions.

RESULTS: In this evaluation of the dispensing of naloxone across the United States, NALs granting direct authority to pharmacists were associated with significant reductions in fatal overdoses, but they may also increase nonfatal overdoses seen in emergency department visits. The effect sizes for fatal overdoses grew over time relative to adoption of the NALs. These policies were estimated to reduce opioid-rated fatal overdoses by 0.387 (95% CI, 0.119-0.656; P = .007) per 100 000 people in 3 or more years after adoption. There was little evidence of an association for indirect authority to dispense (increase by 0.121; 95% CI, -0.014 to 0.257; P = .09) and other NALs (increase by 0.094; 95% CI, -0.040 to 0.227; P = .17).

CONCLUSIONS AND RELEVANCE: Although many states have passed some type of law affecting naloxone availability, only laws allowing direct dispensing by pharmacists appear to be useful. Communities in which access to naloxone is improved should prepare for increases in nonfatal overdoses and link these individuals to effective treatment.

来源:JAMA Intern Med,查看原文。版权归原作者所有。

参考来源

  1. Abouk R, Pacula RL, Powell D, et al. Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose. JAMA Intern Med. 2019. PMID: 31058922. doi:10.1001/jamainternmed.2019.0272

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。